97 related articles for article (PubMed ID: 15966777)
1. In vitro determination of the optimal particle size for nebulized aerosol delivery to infants.
Schüepp KG; Jauernig J; Janssens HM; Tiddens HA; Straub DA; Stangl R; Keller M; Wildhaber JH
J Aerosol Med; 2005; 18(2):225-35. PubMed ID: 15966777
[TBL] [Abstract][Full Text] [Related]
2. Determining factors of aerosol deposition for four pMDI-spacer combinations in an infant upper airway model.
Janssens HM; Krijgsman A; Verbraak TF; Hop WC; de Jongste JC; Tiddens HA
J Aerosol Med; 2004; 17(1):51-61. PubMed ID: 15120013
[TBL] [Abstract][Full Text] [Related]
3. Effect of nebulizer configuration on delivery of aerosolized tobramycin.
O'Riordan TG; Amram JC
J Aerosol Med; 1997; 10(1):13-23. PubMed ID: 10166359
[TBL] [Abstract][Full Text] [Related]
4. Effects of equipment dead space and pediatric breathing patterns on inhaled mass of nebulized budesonide.
Nikander K; Denyer J; Smaldone GC
J Aerosol Med; 1999; 12(2):67-73. PubMed ID: 10539709
[TBL] [Abstract][Full Text] [Related]
5. Aerosol delivery of recombinant human DNase I: in vitro comparison of a vibrating-mesh nebulizer with a jet nebulizer.
Johnson JC; Waldrep JC; Guo J; Dhand R
Respir Care; 2008 Dec; 53(12):1703-8. PubMed ID: 19025706
[TBL] [Abstract][Full Text] [Related]
6. In vitro delivery of budesonide from 30 jet nebulizer/compressor combinations using infant and child breathing patterns.
Berg EB; Picard RJ
Respir Care; 2009 Dec; 54(12):1671-8. PubMed ID: 19961633
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution.
Pham S; Ferguson GT; Kerwin E; Goodin T; Wheeler A; Bauer A
J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):162-169. PubMed ID: 29125918
[TBL] [Abstract][Full Text] [Related]
8. Capturing the efficiency of vibrating mesh nebulizers: minimizing upper airway deposition.
Sagalla RB; Smaldone GC
J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):341-8. PubMed ID: 25105472
[TBL] [Abstract][Full Text] [Related]
9. Facial and ocular deposition of nebulized budesonide: effects of face mask design.
Harris KW; Smaldone GC
Chest; 2008 Feb; 133(2):482-8. PubMed ID: 18071018
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of nebulizer performance under various humidity conditions.
Zhou Y; Ahuja A; Irvin CM; Kracko D; McDonald JD; Cheng YS
J Aerosol Med; 2005; 18(3):283-93. PubMed ID: 16181003
[TBL] [Abstract][Full Text] [Related]
11. From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.
Bianco F; Ricci F; Catozzi C; Murgia X; Schlun M; Bucholski A; Hetzer U; Bonelli S; Lombardini M; Pasini E; Nutini M; Pertile M; Minocchieri S; Simonato M; Rosa B; Pieraccini G; Moneti G; Lorenzini L; Catinella S; Villetti G; Civelli M; Pioselli B; Cogo P; Carnielli V; Dani C; Salomone F
Respir Res; 2019 Jul; 20(1):134. PubMed ID: 31266508
[TBL] [Abstract][Full Text] [Related]
12. Effect of tidal volume on the output and particle size distribution of hypertonic saline from an ultrasonic nebulizer.
Riedler J; Robertson CF
Eur Respir J; 1994 May; 7(5):998-1002. PubMed ID: 8050559
[TBL] [Abstract][Full Text] [Related]
13. Effect of tubing deposition, breathing pattern, and temperature on aerosol mass distribution measured by cascade impactor.
Gurses BK; Smaldone GC
J Aerosol Med; 2003; 16(4):387-94. PubMed ID: 14977429
[TBL] [Abstract][Full Text] [Related]
14. Delivery of nebulized budesonide is affected by nebulizer type and breathing pattern.
O'Callaghan C; White J; Jackson J; Barry PW; Kantar A
J Pharm Pharmacol; 2005 Jun; 57(6):787-90. PubMed ID: 15969935
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of aerosol delivery of aztreonam lysine (AZLI): an adult mechanical ventilation model.
Rodríguez A; Cabrera M; Reyes LF; Bodí M; Trefler S; Canadell L; Barahona D; Ehrmann S; Martin-Loeches I; Restrepo MI; Vecellio L
Expert Opin Drug Deliv; 2017 Dec; 14(12):1447-1453. PubMed ID: 29041861
[TBL] [Abstract][Full Text] [Related]
16. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
[TBL] [Abstract][Full Text] [Related]
17. Effect of mask dead space and occlusion of mask holes on delivery of nebulized albuterol.
Berlinski A
Respir Care; 2014 Aug; 59(8):1228-32. PubMed ID: 24327744
[TBL] [Abstract][Full Text] [Related]
18. Nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy.
Berlinski A
Respir Care; 2013 Dec; 58(12):2076-86. PubMed ID: 23674810
[TBL] [Abstract][Full Text] [Related]
19. Special problems in aerosol delivery: neonatal and pediatric considerations.
Cole CH
Respir Care; 2000 Jun; 45(6):646-51. PubMed ID: 10894457
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Performance of an Investigational Vibrating-Membrane Nebulizer with Surfactant under Simulated, Non-Invasive Neonatal Ventilation Conditions: Influence of Continuous Positive Airway Pressure Interface and Nebulizer Positioning on the Lung Dose.
Bianco F; Pasini E; Nutini M; Murgia X; Stoeckl C; Schlun M; Hetzer U; Bonelli S; Lombardini M; Milesi I; Pertile M; Minocchieri S; Salomone F; Bucholski A
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32178276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
